Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1994-2-14
pubmed:abstractText
The emergence of acquired high-level resistance among Enterococcus species has renewed interest in mechanisms of resistance to glycopeptide antibiotics in gram-positive bacteria. In Enterococcus faecalis and Enterococcus faecium, resistance is encoded by the van gene cluster and is due to the production of a peptidoglycan precursor terminating in D-alanyl-D-lactate, to which vancomycin does not bind. Most Leuconostoc and many Lactobacillus species are intrinsically resistant to high levels of glycopeptide antibiotics, but the mechanism of resistance has not been elucidated. To determine whether the mechanisms of resistance are similar in intrinsically resistant bacteria, cytoplasmic peptidoglycan precursors were isolated from Leuconostoc mesenteroides and Lactobacillus casei and analyzed by mass spectrometry, revealing structures consistent with UDP-N-acetylmuramyl-L-Ala-D-Glu-L-Lys-(L-Ala)-D-Ala-D-lactate and UDP-N-acetylmuramyl-L-Ala-D-Glu-L-Lys-D-Ala-D-lactate, respectively.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8282706-1459398, http://linkedlifedata.com/resource/pubmed/commentcorrection/8282706-1503457, http://linkedlifedata.com/resource/pubmed/commentcorrection/8282706-1521770, http://linkedlifedata.com/resource/pubmed/commentcorrection/8282706-1522072, http://linkedlifedata.com/resource/pubmed/commentcorrection/8282706-1931965, http://linkedlifedata.com/resource/pubmed/commentcorrection/8282706-1998664, http://linkedlifedata.com/resource/pubmed/commentcorrection/8282706-2201065, http://linkedlifedata.com/resource/pubmed/commentcorrection/8282706-2291654, http://linkedlifedata.com/resource/pubmed/commentcorrection/8282706-2817848, http://linkedlifedata.com/resource/pubmed/commentcorrection/8282706-2833158, http://linkedlifedata.com/resource/pubmed/commentcorrection/8282706-3182995, http://linkedlifedata.com/resource/pubmed/commentcorrection/8282706-4248526, http://linkedlifedata.com/resource/pubmed/commentcorrection/8282706-5124386, http://linkedlifedata.com/resource/pubmed/commentcorrection/8282706-622161, http://linkedlifedata.com/resource/pubmed/commentcorrection/8282706-6517580, http://linkedlifedata.com/resource/pubmed/commentcorrection/8282706-6798933, http://linkedlifedata.com/resource/pubmed/commentcorrection/8282706-8215264, http://linkedlifedata.com/resource/pubmed/commentcorrection/8282706-8380148, http://linkedlifedata.com/resource/pubmed/commentcorrection/8282706-8421278
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0021-9193
pubmed:author
pubmed:issnType
Print
pubmed:volume
176
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
260-4
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1994
pubmed:articleTitle
Vancomycin-resistant Leuconostoc mesenteroides and Lactobacillus casei synthesize cytoplasmic peptidoglycan precursors that terminate in lactate.
pubmed:affiliation
Laboratory of Microbiology, Rockefeller University, New York, New York 10021.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.